Prevalence of potential drug–drug interactions in outpatients of a general hospital in China: a retrospective investigation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalence of potential drug–drug interactions in outpatients of a general hospital in China: a retrospective investigation
Authors
Keywords
-
Journal
International Journal of Clinical Pharmacy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-03
DOI
10.1007/s11096-020-01068-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients
- (2019) Fabiola Medina-Barajas et al. Pediatrics and Neonatology
- The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan
- (2019) Mohammad B. Nusair et al. SAUDI PHARMACEUTICAL JOURNAL
- Risk factors for potential drug-drug interactions in intensive care unit patients
- (2018) Slobodan M. Janković et al. JOURNAL OF CRITICAL CARE
- The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software
- (2018) Ginah Nightingale et al. Journal of Geriatric Oncology
- Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study
- (2018) Mohammad Ismail et al. BMC HEALTH SERVICES RESEARCH
- Potential Drug-drug Interactions at a Referral Pediatric Oncology Ward in Iran
- (2018) Faezeh Tavousi et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Pattern and Appropriateness of Medicines Prescribed to Outpatients at a University Hospital in Northwestern Ethiopia
- (2017) Fitsum Sebsibe Teni et al. Biomed Research International
- Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and Older
- (2016) Jonas W. Wastesson et al. Journal of the American Medical Directors Association
- Potential drug–drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan
- (2016) Mohammad Ismail et al. International Journal of Clinical Pharmacy
- Potential drug–drug interactions in hospitalised haematological patients
- (2016) Ma Ángeles Fernández de Palencia Espinosa et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Prevalence and Predictors of Potential Drug-Drug Interactions in the Elderly: A Cross-Sectional Study in the Brazilian Primary Public Health System
- (2016) Paulo Roque Obreli Neto et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
- (2015) Bruce Guthrie et al. BMC Medicine
- Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction
- (2015) Almudena Ribed et al. International Journal of Clinical Pharmacy
- Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines
- (2015) S. Dumbreck et al. BMJ-British Medical Journal
- Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines
- (2015) S. Dumbreck et al. BMJ-British Medical Journal
- Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
- (2013) R W F van Leeuwen et al. BRITISH JOURNAL OF CANCER
- Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method
- (2011) R. W. .F. van Leeuwen et al. ANNALS OF ONCOLOGY
- Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions
- (2011) Lara Magro et al. Expert Opinion On Drug Safety
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started